ERBB2 and breast carcinoma: However, using YAMAT‐seq method, Shigematsu et al. showed variations in the expression levels of mature tRNAs between three different subtypes of breast cancer cell lines, MCF7 (luminal A subtype), SK‐BR‐3 (HER2‐positive subtype) and BT‐20 (triple negative subtype) [61].